IP Verse

Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs - EP3411402

The patent EP3411402 was granted to Amgen on Dec 22, 2021. The application was originally filed on Feb 2, 2017 under application number EP17703376A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3411402

AMGEN
Application Number
EP17703376A
Filing Date
Feb 2, 2017
Status
Granted And Under Opposition
Nov 19, 2021
Grant Date
Dec 22, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANSep 14, 2022VASILESCUADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2012088461
INTERNATIONAL-SEARCH-REPORTWO2013072406
INTERNATIONAL-SEARCH-REPORTWO2014122143
INTERNATIONAL-SEARCH-REPORTWO2014138449
OPPOSITIONUS2009252729
OPPOSITIONWO2009132058
OPPOSITIONWO2012088461
OPPOSITIONWO2013072406
OPPOSITIONWO2013072415
OPPOSITIONWO2014122143
OPPOSITIONWO2014138449

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- S HIPP ET AL, "A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo", LEUKEMIA., US, (20170113), doi:10.1038/leu.2016.388, ISSN 0887-6924, XP055338781 [T] * the whole document *
OPPOSITION- Caroline Hetwick, "Bispecific Antibodies Successes and Challenges", The ASCO Post, (20200410), URL: https://ascopost.com/, XP055964785-
OPPOSITION- KONTERMANN ROLAND E ET AL, "Bispecific antibodies.", DRUG DISCOVERY TODAY SEP 2012, (20150701), vol. 20, no. 7, ISSN 1878-5832, pages 838 - 847, XP002770308-
OPPOSITION- Amelia M Huehls; Tiffany A Coupet; Charles L Sentman, "Bispecific T‐cell engagers for cancer immunotherapy", IMMUNOLOGY AND CELL BIOLOGY, CARLTON, AU, AU , (20141104), vol. 93, no. 3, doi:10.1038/icb.2014.93, ISSN 0818-9641, pages 290 - 296, XP071704414
OPPOSITION- KONTERMANN ROLAND E, "Recombinant bispecific antibodies for cancer therapy", Acta Pharmacologica Sinica, Nature Publishing Group, GB, GB , (20050101), vol. 26, no. 1, doi:10.1111/j.1745-7254.2005.00008.x, ISSN 1671-4083, pages 1 - 9, XP002426874
OPPOSITION- Hipp Susanne; Deegen Petra; Wahl Joachim; Blanset Diann; Thomas Oliver; Rattel Benno; Adam Paul; Friedrich Matthias, "BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo", Blood, American Society of Hematology, US, US , (20151203), vol. 126, no. 23, doi:10.1182/blood.V126.23.2999.2999, ISSN 0006-4971, page 2999, XP086651056
OPPOSITION- Jingjing Wu, Jiaping Fu, Mingzhi Zhang and Delong Liu, "Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia. Art. 104.", Journal of Hematology & Oncology, BioMed Central Ltd, London UK, London UK , (20150904), vol. 8, doi:10.1186/s13045-015-0195-4, ISSN 1756-8722, pages 1 - 7, XP002764048
OPPOSITION- Gaowei Fan, Zujian Wang, Mingju Hao, Jinming Li, "Bispecific antibodies and their applications", Journal of Hematology & Oncology, (20151201), vol. 8, no. 130, doi:10.1186/s13045-015-0227-0, pages 1 - 14, XP055298353
OPPOSITION- Nan Wang, Liang Hongwei, Zen Ke, "Molecular Mechanisms That Influence the Macrophage M1-M2 Polarization Balance", Frontiers in Immunology, Frontiers Media, Lausanne, CH, Lausanne, CH , (20141128), vol. 5, doi:10.3389/fimmu.2014.00614, ISSN 1664-3224, XP055716765

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents